Teleflex Incorporated

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 21:00:01 16/07/2024 BST			5-day change	1st Jan Change
229.3 ^USD	+4.29%		+5.14%	-8.05%

07-16	Truist Raises Price Target on Teleflex to $240 From $235, Maintains Hold Rating	MT
07-09	Truist Securities Adjusts Price Target on Teleflex to $235 From $219, Maintains Hold Rating	MT

Teleflex Incorporated(NYSE:TFX) dropped from S&P 400

January 18, 2019 at 05:00 am

Latest news about Teleflex Incorporated

Truist Raises Price Target on Teleflex to $240 From $235, Maintains Hold Rating	07-16	MT
Truist Securities Adjusts Price Target on Teleflex to $235 From $219, Maintains Hold Rating	07-09	MT
Piper Sandler Upgrades Teleflex to Overweight From Neutral, Adjusts Price Target to $245 From $205	07-01	MT
Teleflex Incorporated(NYSE:TFX) added to Russell 2500 Value Index	06-30	CI
Teleflex Incorporated(NYSE:TFX) dropped from Russell 1000 Value-Defensive Index	06-30	CI
Teleflex Incorporated(NYSE:TFX) dropped from Russell 1000 Defensive Index	06-30	CI
Teleflex Incorporated(NYSE:TFX) added to Russell 2500 Index	06-30	CI
RBC Cuts Price Target on Teleflex to $235 From $255, Maintains Outperform Rating	06-21	MT
US FDA classifies recall of Teleflex's inflatable devices as 'most serious'	06-13	RE
Transcript : Teleflex Incorporated Presents at Bank of America Health Care Conference 2024, May-14-2024 02:20 PM	05-14
Teleflex Incorporated Expands Intraosseous Vascular Access Portfolio with New Arrow? EZ-IO? Intraosseous Access Procedure Tray	05-09	CI
Teleflex Maintains Dividend at $0.34 per Share; Payable on June 14 to Shareholders of Record on May 15	05-06	MT
Teleflex Incorporated Announces Quarterly Cash Dividend, Payable on June 14, 2024	05-06	CI
Raymond James Adjusts Price Target on Teleflex to $241 From $271	05-03	MT
Truist Adjusts Teleflex's PT to $219 From $240, Keeps Hold Rating	05-03	MT
Jefferies Adjusts Price Target on Teleflex to $240 From $250	05-03	MT
RBC Capital Adjusts Price Target on Teleflex to $255 From $265	05-03	MT
Wells Fargo Cuts Price Target on Teleflex to $210 From $265	05-02	MT
Teleflex's Fiscal Q1 Adjusted Earnings, Net Revenue Increase; Raises Low End of Fiscal 2024 Adjusted Profit Guidance	05-02	MT
Transcript : Teleflex Incorporated, Q1 2024 Earnings Call, May 02, 2024	05-02
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q1 Revenue $737.8M	05-02	MT
Earnings Flash (TFX) TELEFLEX INCORPORATED Reports Q1 EPS $3.21	05-02	MT
Teleflex Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	05-02	CI
Teleflex Incorporated Raises Earnings Guidance for the Full Year 2024	05-02	CI
Teleflex Incorporated Lowers Revenue Growth Guidance for Full Year 2024	05-02	CI

Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

24/07/2024 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Teleflex Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

229.3 USD

Average target price

248.1 USD

Spread / Average Target

+8.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
TELEFLEX INCORPORATED	-8.05%	10.8B
ABBOTT LABORATORIES	-6.68%	179B
MEDTRONIC PLC	-5.20%	100B
BECTON, DICKINSON AND COMPANY	-5.38%	66.67B
HOYA CORPORATION	+18.44%	44.81B
DEXCOM, INC.	-6.47%	46.16B
CENCORA, INC.	+9.74%	44.38B
METTLER-TOLEDO INTERNATIONAL, INC.	+14.01%	29.53B
TERUMO CORPORATION	+22.03%	25.83B
WEST PHARMACEUTICAL SERVICES, INC.	-6.53%	23.97B

Other Medical Equipment, Supplies & Distribution